The main category of All News Articles.
You can use the search box below to find what you need.
[wd_asp id=1]
The main category of All News Articles.
You can use the search box below to find what you need.
[wd_asp id=1]
Alvin Lang
Dec 03, 2025 08:01
MATIC price prediction points to $0.45 medium-term target despite trading at $0.38, with critical $0.58 resistance determining bullish continuation.
Polygon (MATIC) finds itself at a critical juncture as December 2025 unfolds, trading at $0.38 and showing signs of consolidation near multi-month lows. Our comprehensive MATIC price prediction analysis reveals a mixed technical picture that suggests moderate upside potential, contingent on breaking key resistance levels that have proven stubborn throughout the recent bearish cycle.
• MATIC short-term target (1 week): $0.40 (+5.3%)
• Polygon medium-term forecast (1 month): $0.42-$0.48 range
• Key level to break for bullish continuation: $0.58
• Critical support if bearish: $0.33
Recent analyst consensus points to cautious optimism for MATIC’s price trajectory. Blockchain.News has consistently maintained medium-term targets between $0.42-$0.52 across multiple forecasts, with their latest Polygon forecast suggesting a $0.42-$0.48 range representing 11-26% upside potential from current levels.
The analytical community appears divided on timing but unified on the importance of the $0.58 resistance level. This critical threshold has emerged as the make-or-break point that will determine whether MATIC can mount a sustained recovery or remain range-bound. The consensus MATIC price prediction reflects moderate confidence levels, with most analysts acknowledging the challenging technical environment while recognizing oversold conditions that could fuel a bounce.
Current Polygon technical analysis reveals a cryptocurrency in transition, displaying characteristics of both oversold conditions and bearish momentum. The RSI reading of 38.00 positions MATIC in neutral territory, suggesting the selling pressure that drove the token down 70% from its 52-week high of $1.27 may be exhausting itself.
The MACD histogram at -0.0045 continues to flash bearish signals, but the narrowing momentum divergence hints at potential stabilization. More telling is MATIC’s position within the Bollinger Bands at 0.2879, indicating the price is trading in the lower portion of its recent range but not at extreme oversold levels that typically precede sharp reversals.
Volume analysis from Binance spot trading shows $1.07 million in 24-hour turnover, representing below-average participation that often characterizes consolidation phases. The daily ATR of $0.03 suggests relatively contained volatility, which could indicate accumulation by longer-term holders ahead of the next directional move.
The optimistic MATIC price prediction scenario envisions a structured recovery that begins with reclaiming the $0.42 level (EMA 26), followed by a test of the $0.45-$0.48 resistance zone. This Polygon forecast aligns with the SMA 50 at $0.45, making it a natural profit-taking area for any sustained bounce.
For the bullish case to materialize, MATIC must first establish support above the current pivot point of $0.38, then demonstrate the ability to hold gains above the SMA 7 at $0.37. The critical MATIC price target remains $0.58, where breaking this level would signal a fundamental shift in market structure and potentially open the door to $0.70+ targets over the medium term.
Technical confirmation would come from RSI moving above 50, MACD histogram turning positive, and sustained volume above the recent average. The timeline for this scenario spans 4-6 weeks, requiring patience as MATIC works through overhead resistance.
The downside MATIC price prediction centers on a break below the immediate support at $0.35, which would likely trigger stops and push the token toward the strong support zone at $0.33. This level represents approximately the 52-week low area and would constitute a significant technical failure.
A breakdown scenario would likely be accompanied by broader cryptocurrency market weakness and could see MATIC testing the $0.30 psychological level. The bearish case gains credibility if the RSI fails to hold above 35 or if the MACD histogram extends deeper into negative territory without signs of stabilization.
Risk factors include continued institutional selling pressure, broader market correction, or failure to demonstrate utility growth within the Polygon ecosystem. The timeline for bearish development would be more compressed, potentially playing out over 2-3 weeks.
The current technical setup suggests a measured approach rather than aggressive accumulation. For those considering whether to buy or sell MATIC, the optimal entry strategy involves scaling into positions on any weakness toward the $0.35 support level, with initial stop-losses placed below $0.33.
Conservative traders should wait for confirmation above $0.40 before initiating positions, as this would suggest the immediate downtrend is breaking. More aggressive investors might consider dollar-cost averaging between $0.35-$0.38, recognizing the proximity to established support levels.
Position sizing should remain modest given the mixed technical signals, with no single entry representing more than 2-3% of portfolio allocation. The risk-reward profile favors patience, as the spread between current price and both upside targets ($0.45+) and downside risks ($0.33) provides reasonable asymmetry for disciplined entries.
Our comprehensive MATIC price prediction points to a $0.42-$0.48 target range over the next 4-6 weeks, representing 11-26% upside potential from current levels. This Polygon forecast carries medium confidence given the mixed technical signals and broader market uncertainty affecting cryptocurrency valuations.
The key indicators to monitor for confirmation include RSI movement above 45, MACD histogram stabilization, and most critically, price action around the $0.58 resistance level. Invalidation of the bullish thesis would come from a decisive break below $0.35 on sustained volume.
The timeline for this prediction extends through January 2026, with initial signals expected within 2-3 weeks as MATIC either confirms support at current levels or breaks down toward deeper oversold conditions. Traders should remain flexible and ready to adjust positions based on these key technical developments that will determine MATIC’s near-term trajectory.
Image source: Shutterstock
Silver declined in its latest intraday trading after the important resistance level at $58.80 held, as the price attempts to acquire positive momentum that may help it break this resistance. At the same time, silver is trying to relieve part of its clear overbought saturation on the RSI indicators, especially with the arrival of negative signal inflows. This comes under the dominance of the main short-term ascending trend, with the price moving alongside both primary and secondary trendlines that support this path.
The US dollar rallied a bit against the Japanese yen during the trading session on Tuesday, as we continue to see this market trying to recover. Ultimately, I think we are probably in a timeframe of noisy volatility, and that noisy volatility will continue to be the overall theme, I think not only of this pair, but probably several others.
Looking back over the last several months, we have seen a lot of strength coming out of the US dollar, and sooner or later, there has to be a little bit of a pullback. And I think that’s all we are seeing here. Yes, the Federal Reserve has an interest rate decision next Wednesday, and it very well could be an interest rate cut. But the reality is, the interest rate differential between these two currencies will remain wide enough to drive a truck through.
And with that being the case, I just don’t see why you would get short of this market unless we get some type of financial meltdown. That being said, the first quarter of 2026 should be very strong for the US economy, from some of the leading indicators that I follow. And therefore, I think the US dollar will continue to strengthen against most currencies. I don’t necessarily think this is a scenario where it’s going to be straight up in the air, but I do recognize that there’s a very real world in which there is just a grind higher.
I think that ends up being the overall theme here, and with that, I remain a buyer of dips. I have no interest in shorting this market, nor would I even be concerned about the trend until we broke down below the 153 yen level, where the 50-day EMA and previous support and resistance show themselves.
Want to trade our USD/JPY forex analysis and predictions? Here’s a list of forex brokers in Japan to check out.
Christopher Lewis has been trading Forex and has over 20 years experience in financial markets. Chris has been a regular contributor to Daily Forex since the early days of the site. He writes about Forex for several online publications, including FX Empire, Investing.com, and his own site, aptly named The Trader Guy. Chris favours technical analysis methods to identify his trades and likes to trade equity indices and commodities as well as Forex. He favours a longer-term trading style, and his trades often last for days or weeks.
Green tea is not necessarily the best when it comes to its flavour or its rather mild personality. However, this unassuming beverage, consumed worldwide, is packed with antioxidants that improve your health. In fact, Dr William Li, a Harvard-trained doctor, researcher, and author of Eat To Beat Your Diet, is urging people to make green tea a part of their daily diet. In a blog, the doctor talks about the three compelling reasons why green tea should be consumed every day. What are they? Let’s take a look.
Yes, that’s right. The potent antioxidants called catechins may help protect you from cancer. “There are remarkable epidemiological studies supporting green tea,” the doctor said. A 2007 study published by the American Association for Cancer Research found that green tea can slash the risk of colon cancer. “The Shanghai Women’s Health Study followed 69,000 women and found that those who drank tea at least three times per week had a 37% reduction in the risk for colon cancer, compared to women who didn’t drink green tea,” the doctor explained. Dr Li added that the way you steep the tea could also make a huge difference. “The more you steep, the more natural cancer-fighting substances from the tea leaves are released into your cup! Dunking a tea bag up and down for a few minutes is better than letting the bag just sit on the bottom of the cup,” he said.
Green tea has antioxidants that protect your DNA from oxidative damage. “Your DNA is the blueprint for your health. Green tea contains a bioactive called EGCG that makes a natural antioxidant enzyme called GSTP1 that protects your DNA from oxidative stress,” the doctor said. He added, “By the way, EGCG can also activate tumour-suppressor genes that stop cancer cells from growing.”
Another potential benefit of drinking green tea every day is that it can reduce stress. A 2006 study published in The American Journal of Clinical Nutrition found that green tea is linked to lower psychological stress. The participants of the study were 2,774 people in Japan living with high levels of psychological stress. “It was found that those who drank five or more cups of green tea daily exhibited fewer stress symptoms,” Dr Li added. Another 2004 study by Loma Linda University researchers, published in JAMA, showed that regular green tea consumption lowered blood pressure. “Green tea also helps reduce blood pressure, which can be raised when you are stressed out,” Dr Li said. Referring to the study, he added that the participants “who drank half a cup per day of green or oolong tea were 46% less likely to develop high blood pressure than non-tea drinkers. The risk reduction increased to 65% for those who drank two and a half cups of tea or more per day.” Sometimes, simple lifestyle changes can make a huge impact. Case in point: regular consumption of green tea. “Although we can’t always change the things in our lives that cause us stress, we can drink tea to help counter the effects on our mental and physical health,” the doctor added.Note: The information provided in this article is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any new medication or treatment, or before changing your diet or supplement regimen.
Dogecoin (DOGE) is trading near $0.1445 after a 24-hour gain of about 5.44%, setting the stage for a focused DOGE outlook. Market data from CoinMarketCap and TradingView show modest upside inside a fragile structure, and analyst Ali Martinez highlights the critical $0.14 support level as a pivot for short-term risk.
This Dogecoin (DOGE) Price Prediction piece examines how technicals and social metrics support DOGE’s incumbent position even as new entrants press the market. PHOENIX and Crypto News & Analytics report that DOGE still leads in social engagement, which underpins investor confidence and liquidity.
At the same time, presale-driven projects and Bitcoin Hyper (https://bitcoinhyper.com/) adopt low entry prices and whitelist mechanics to pull capital and attention. The DOGE vs HYPER dynamic frames a broader debate over meme coin dominance, where structured presales and novel tokenomics can challenge legacy momentum.
The following section will detail price action, key supports and resistances, and technical indicators to shape a practical DOGE outlook for traders and investors.
Market snapshot and short-term technical outlook for Dogecoin (DOGE)
Dogecoin is showing mixed signals after a short uptick near $0.1445, with a 5.44% gain in the past 24 hours that points to renewed buying interest. The intraday rally sits against a daily structure of lower highs and lower lows on TradingView, so traders should treat gains with caution. Watching DOGE price action over the next few sessions will clarify whether buyers can change the trend.
Current price action and momentum
Short-term DOGE momentum has improved slightly, yet the broader trend remains bearish on the one-day chart. The $0.14 zone, highlighted by analyst Ali Martinez, has acted as a historic demand area. Recent slips below that level undermine bullish conviction and suggest sellers retain control until higher lows form on daily closes.
Key support and resistance levels to watch
The immediate support sits at $0.14, a key demand area that has been tested and briefly breached. If that level fails to hold, sequential downside targets include $0.13, $0.12, and $0.10. A much deeper structural floor near $0.07 serves as a longer-term backup if multiple supports cascade.
The nearest resistance is around $0.16, the zone DOGE previously failed to clear and the next meaningful supply area on any rebound. Price needs to reclaim $0.14-$0.16 and then produce higher highs to shift the bias back to buyers.
Technical indicators summary
Daily DOGE technical indicators keep the bias tilted to the downside. The RSI sits near 35, close to oversold territory but not yet signaling a clear reversal. The MACD remains below its signal line with negative histogram bars, showing persistent bearish pressure.
Taken together, DOGE RSI MACD and other indicators point to limited upside until price proves strength above key levels. Traders should monitor DOGE technical indicators and DOGE support resistance behavior to gauge whether momentum can flip from bearish to bullish.
Dogecoin (DOGE) Price Prediction
This part lays out clear directional scenarios for traders and holders. Use the next sections to compare downside and upside paths, with specific DOGE targets and guidance for position sizing and DOGE risk management.
Bearish scenario: extension of decline
If Dogecoin stays below $0.14 and keeps making lower highs and lower lows, expect an extension of the sell-off. A first sequence of stops sits near $0.13 and $0.12, with $0.10 acting as a historically significant pause zone on Ali Martinez’s roadmap.
Daily momentum indicators add weight to the downside view. The RSI close to the mid-30s and a negative MACD histogram suggest sellers remain in control until those readings turn.
Should multiple demand zones fail, deeper structural support near $0.07 could be tested over time. Traders should set DOGE risk management rules now, using smaller position sizes and tight stops to limit losses in a protracted decline.
Bullish scenario: rebound from support
A solid reclaim of $0.14 followed by a daily close above $0.16 would shift the edge toward buyers. That sequence would open a path back into the prior consolidation range and create short-term DOGE targets above $0.16.
Technical confirmation would come from RSI moving back above neutral and MACD turning positive. Renewed social interest and broader crypto strength could amplify that move as retail sentiment returns.
Active DOGE risk management remains important during a rebound. Trail stops and defined profit-taking levels help lock gains while the market tests new resistance zones.
Timeframe-based projections and risk considerations
Short-term (days to weeks): expect choppy action around $0.14-$0.16. A breakdown would set immediate DOGE targets near $0.13-$0.10. A reclaim would target $0.16 and above for follow-through moves.
Medium-term (weeks to months): the market’s ability to form higher lows will determine whether recovery holds. Failure to reestablish that structure raises the risk of deeper retracement toward $0.07 over an extended bear phase.
Key risks include technical breakdowns, broader crypto market shocks, and capital rotation into presale meme projects that draw speculative funding away from Dogecoin. Prudent DOGE risk management-position sizing, stop-loss orders, and scenario planning-helps protect capital across both bullish and bearish outcomes.
How Bitcoin Hyper (HYPER) and new meme coins challenge DOGE’s dominance
New meme projects are reshaping attention and capital flows in crypto. Bitcoin Hyper (HYPER) (https://bitcoinhyper.com/) and several presale-driven launches use staged distribution and marketing to capture retail interest. That pattern changes how traders discover upside and how narrative momentum forms around tokens.
Competition from HYPER and presale-driven projects
Structured presales create urgency with whitelists, staggered pricing, and limited allocation. These mechanics help presale tokens push a concentrated bid into the market during initial listing. The Apeing presale model shows how a $0.0001 entry price plus staged rounds can attract many small buyers seeking first-mover advantages.
That approach contrasts with Dogecoin’s looser issuance and grassroots marketing. Presale mechanics can compress demand and produce fast price discovery, drawing speculative capital away from established coins in short bursts.
Social activity and community influence
Social leadership still matters. Dogecoin’s brand and large user base keep it highly visible across platforms. Recent reports showed DOGE leading meme coin social metrics with intense posting and interactions that sustain retail flow and headlines.
At the same time, smaller projects can concentrate narrative building within tight communities. Projects that drive viral threads and coordinated posting often convert social momentum into rapid trading volume. That dynamic fragments attention and fuels meme coin competition for new entrants and capital.
Structural advantages vs. novel tokenomics
Dogecoin’s advantages include deep brand recognition, practical tipping use cases, and a broad social footprint. Those features support steady retail interest and long-term awareness.
Novel tokenomics and presale setups offer engineered scarcity and clearer early-stage upside. Investors facing HYPER (https://bitcoinhyper.com/) vs DOGE must weigh brand stability against the high-risk, high-reward narratives of presale tokens. Presale tokens can deliver outsized short-term returns but carry concentrated risk compared with Dogecoin’s established ecosystem.
Implications for investors and trading strategies in the evolving meme-coin landscape
Investors should treat DOGE trading strategy as a mix of technical discipline and position sizing. Monitor the immediate pivot at $0.14: a daily close below it raises downside targets toward $0.13-$0.10 and possibly $0.07, while reclaiming $0.16 with higher-lows supports bullish setups. Use RSI and MACD with price structure to time entries; current momentum readings near RSI 35 and a negative MACD warrant caution before committing larger capital.
Risk controls are essential given meme coin investment volatility. Apply strict DOGE risk management with clear stop-losses and modest position sizes for newly launched tokens. For presale investment risks, limit exposure to a small, predefined percentage of capital and treat whitelist deals as high-risk, high-reward plays rather than core holdings. This keeps drawdowns manageable while preserving upside participation.
Watch capital rotation into presale-driven projects like Apeing and similar low-entry tokens that can siphon social momentum from Dogecoin. Track social metrics and on-chain activity as early indicators of retail flows; Dogecoin’s large engagement remains a stabilizing factor but can be outpaced by concentrated presale hype. Blend technical signals with sentiment to refine timing and avoid chasing narratives.
For longer-term portfolios, balance crypto portfolio allocation between established meme assets and speculative stakes. Allocate larger conviction to established tokens only when fundamentals and technicals align, and reserve small, controlled bets for presales. This approach preserves exposure to upside while maintaining prudent DOGE risk management and overall capital protection.
Buchenweg 15, Karlsruhe, Germany
For more information about Bitcoin Hyper (HYPER) visit the links below:
Website: https://bitcoinhyper.com/
Whitepaper: https://bitcoinhyper.com/assets/documents/whitepaper.pdf
Telegram: https://t.me/btchyperz
Twitter/X: https://x.com/BTC_Hyper2
Disclosure: Crypto is a high-risk asset class. This article is provided for informational purposes and does not constitute investment advice.
CryptoTimes24 is a digital media and analytics platform dedicated to providing timely, accurate, and insightful information about the cryptocurrency and blockchain industry. The enterprise focuses on delivering high-quality news coverage, market analysis, project reviews, and educational resources for both investors and enthusiasts. By combining data-driven journalism with expert commentary, CryptoTimes24 aims to become a trusted global source for emerging trends in decentralized finance (DeFi), NFTs, Web3 technologies, and digital asset markets.
This release was published on openPR.
Near $5.2000, while the positive factors—particularly the alignment of major indicators supporting bullish momentum—will increase the chances of breaking this barrier and beginning to target the next positive levels at $5.3200 and $5.5000 respectively.
We note that a decline in the price during current trading below $4.9700 and a negative closing may force it into forming temporary corrective movements, attempting to test the support level at $4.7500 before any new attempt to reach the suggested targets.
Expected trading range for today: between $5.1200 and $5.3200
Price forecast for today: Bullish
EUR/USD holds its ground and rises to the 1.1650 region in the European morning on Wednesday, after closing in positive territory on Monday and Tuesday. The pair’s technical picture confirms the bullish bias in the near term.
The table below shows the percentage change of Euro (EUR) against listed major currencies this week. Euro was the strongest against the US Dollar.
| USD | EUR | GBP | JPY | CAD | AUD | NZD | CHF | |
|---|---|---|---|---|---|---|---|---|
| USD | -0.40% | -0.02% | -0.34% | -0.06% | -0.55% | -0.35% | -0.22% | |
| EUR | 0.40% | 0.39% | 0.05% | 0.34% | -0.14% | 0.07% | 0.18% | |
| GBP | 0.02% | -0.39% | -0.08% | -0.04% | -0.53% | -0.31% | -0.20% | |
| JPY | 0.34% | -0.05% | 0.08% | 0.28% | -0.22% | -0.00% | 0.11% | |
| CAD | 0.06% | -0.34% | 0.04% | -0.28% | -0.54% | -0.27% | -0.17% | |
| AUD | 0.55% | 0.14% | 0.53% | 0.22% | 0.54% | 0.21% | 0.32% | |
| NZD | 0.35% | -0.07% | 0.31% | 0.00% | 0.27% | -0.21% | 0.11% | |
| CHF | 0.22% | -0.18% | 0.20% | -0.11% | 0.17% | -0.32% | -0.11% |
The heat map shows percentage changes of major currencies against each other. The base currency is picked from the left column, while the quote currency is picked from the top row. For example, if you pick the Euro from the left column and move along the horizontal line to the US Dollar, the percentage change displayed in the box will represent EUR (base)/USD (quote).
The broad-based selling pressure on the US Dollar (USD) on growing expectations for a dovish Federal Reserve (Fed) policy outlook next year helps EUR/USD preserve its bullish momentum. US President Donald Trump hinted that he wants to nominate his chief economic adviser Kevin Hassett, who is widely seen as a dove, to replace outgoing Fed Chairman Jerome Powell next year.
In the second half of the day, the US economic calendar will feature the Automatic Data Processing’s private sector employment data and the Institute for Supply Management’s (ISM) Services Purchasing Managers’ Index (PMI) report for November.
Since the official employment report, which will show Nonfarm Payrolls (NFP) figures, will be released after the Fed meets for the last time this year, investors will pay close attention to the Employment Index of the PMI report.
In case the Employment Index recovers above 50 and reflects an expansion in service sector payrolls, the USD could stage a rebound with the immediate reaction and limit EUR/USD’s upside. On the other hand, a reading below October’s 48.2 could have the opposite impact on the USD’s valuation, opening the door for a leg higher in the pair.
The 20-period Simple Moving Average (SMA) rises above the 50-, 100-, and 200-period SMAs, while price holds above all of them. The 50- and 100-period SMAs edge higher as the 200-period SMA remains flat, with the 20 SMA at 1.1610 offering nearby dynamic support. The 14-period RSI sits at 68, near overbought and consistent with firm momentum.
Measured from the 1.1885 high to the 1.1472 low, EUR/USD holds above the 38.2% retracement at 1.1630, turning the spotlight on the 50% retracement at 1.1679. A sustained break above 1.1679 would open the path toward 1.1730 (Fibonacci 61.8% retracement) and 1.1800 (Fibonacci 78.6% retracement), while failure to defend 1.1630 could send the pair back toward the 200-period SMA at 1.1585 before the static support at 1.1551.
(The technical analysis of this story was written with the help of an AI tool)
The Euro is the currency for the 20 European Union countries that belong to the Eurozone. It is the second most heavily traded currency in the world behind the US Dollar. In 2022, it accounted for 31% of all foreign exchange transactions, with an average daily turnover of over $2.2 trillion a day.
EUR/USD is the most heavily traded currency pair in the world, accounting for an estimated 30% off all transactions, followed by EUR/JPY (4%), EUR/GBP (3%) and EUR/AUD (2%).
The European Central Bank (ECB) in Frankfurt, Germany, is the reserve bank for the Eurozone. The ECB sets interest rates and manages monetary policy.
The ECB’s primary mandate is to maintain price stability, which means either controlling inflation or stimulating growth. Its primary tool is the raising or lowering of interest rates. Relatively high interest rates – or the expectation of higher rates – will usually benefit the Euro and vice versa.
The ECB Governing Council makes monetary policy decisions at meetings held eight times a year. Decisions are made by heads of the Eurozone national banks and six permanent members, including the President of the ECB, Christine Lagarde.
Eurozone inflation data, measured by the Harmonized Index of Consumer Prices (HICP), is an important econometric for the Euro. If inflation rises more than expected, especially if above the ECB’s 2% target, it obliges the ECB to raise interest rates to bring it back under control.
Relatively high interest rates compared to its counterparts will usually benefit the Euro, as it makes the region more attractive as a place for global investors to park their money.
Data releases gauge the health of the economy and can impact on the Euro. Indicators such as GDP, Manufacturing and Services PMIs, employment, and consumer sentiment surveys can all influence the direction of the single currency.
A strong economy is good for the Euro. Not only does it attract more foreign investment but it may encourage the ECB to put up interest rates, which will directly strengthen the Euro. Otherwise, if economic data is weak, the Euro is likely to fall.
Economic data for the four largest economies in the euro area (Germany, France, Italy and Spain) are especially significant, as they account for 75% of the Eurozone’s economy.
Another significant data release for the Euro is the Trade Balance. This indicator measures the difference between what a country earns from its exports and what it spends on imports over a given period.
If a country produces highly sought after exports then its currency will gain in value purely from the extra demand created from foreign buyers seeking to purchase these goods. Therefore, a positive net Trade Balance strengthens a currency and vice versa for a negative balance.
A new cancer nutritional intervention study has demonstrated the link between gut health and prostate cancer.
The research, published in the journal European Urology Oncology, is the largest, most comprehensive evaluation of nutritional interventions in prostate cancer to date.
It demonstrated that the phytochemical rich food blend, YourPhyto, not only significantly slowed PSA progression to a higher degree than previously reported, but also improved urinary symptoms and erectile function.
In addition, this was the world’s first double blind RCT to show that a probiotic also further reduced PSA progression, improved markers of inflammation and grip strength (markers of overall health & longevity).
The trial provides essential scientific evidence for health professionals and practical guidance for people with cancer, interested in empowering themselves with the most effective strategies to improve their well-being and help alleviate the toxicities of hormonal, radiotherapy or surgical treatments.
Men who stopped all other supplements and took two capsules of YourgutPlus along with two capsules of YourPhyto a day showed the following improvements:
YourPhyto contains pomegranate, broccoli, green tea and turmeric, which have all been shown to be beneficial in previous studies conducted by the same research team.
However, the supplement now includes new ingredients and embraces advances in food fortification, safety and technology.
These include purification, measurement and standardisation of the candidate phytochemical ensuring each capsule maintains its effectiveness and safety.
Traditionally supplements either have extracts of plants or dried whole plants — uniquely, this new supplement has both.
This ensures a wide spectrum of synergistically acting natural elements from the whole plant, but also boosts levels of the most active phytochemicals responsible for the health benefits.
During the last ten years, other foods have also demonstrated benefits in studies, particularly cranberry and organic ginger, both of which are included in these new capsules.
Cranberry reduced markers of disease progression and helped urinary urgency. Ginger aided digestion and improved gut health and is a known bio-enhancer, meaning it promotes the absorption of healthy phytochemicals.
Yourgutplus contains five non-histamine inducing, non-diary, lactose secreting lactobacillus bacterial strains, combined with inulin from chicory and vitamin D.
It has been previously evaluated and found to be beneficial in the UK national COVID nutritional intervention study and was chosen for the current covid vaccine support study, thus, has an excellent track record.
Existing research shows that phytochemical intake and probiotics work in synergy to improve gut health and reduce inflammation in the body.
Laboratory studies have already shown that manipulating gut bacteria can slow prostate cancer progression but, until now, no clinical studies in men had investigated combining phytochemicals with probiotics.
As both these capsules were specifically made for national medical trials, the ethical committee insisted on a level of quality assurance unprecedented in supplement manufacturing.
In this double blind randomised clinical trial, men with early but progressive prostate cancer were given the opportunity to try these nutritional interventions before considering treatments such as surgery, radiotherapy or hormone therapies, which have significant risks and toxicities that impact quality of life.
None of the men in the study were taking any other supplements treatments for their prostate cancer.
In an unprecedented result for a nutritional trial, the MRI scans taken before and after the interventions supported the PSA findings. In the combined group, disease on MRI actually reduced in size in seven per cent of paricipants and stabilised in 84%.
Low grip strength (GS), along with inflammation levels is a practical biomarker for increasing age (longevity), the risk of chronic degenerative disease, including cancer.
In younger people — particularly athletes — phytochemical-rich foods and probiotics have independently been shown to improve strength and performance.
However, this is the first study showing a statistically significant effect of a nutritional intervention in an older population.
YourPhyto is now the most up-to-date, comprehensively researched supplement available over the counter.
It’s scientific evaluation not only significantly slowed PSA progression to a higher degree than previously reported, but also improved urinary symptoms and erectile function.
This is the world’s first double blind RCT to demonstrate that a probiotic intervention, Yourgutplus further reduced PSA progression, reduced longevity markers of inflammation and improved grip strength.
This combination has been choice for a major intervention study in women and further trials are planned evaluating their role for enhancing sports performance, strength and longevity.
The crypto market is approaching a tight moment as traders observe how altcoins behave going into the final stretch of the year. Cardano Prediction conversations have begun again, and many crypto investors are following if ADA can stabilize after recent dip.
Market sentiment across digital assets remains mixed, yet several projects continue gaining attention for real progress. One of the names surfacing in crypto news is Remittix, which recently expanded its ecosystem and pushed new updates that position it as a strong competitor in the search for the best crypto to buy now.
Cardano Market Outlook for December
Cardano trades at $0.3997 after posting a 5.33% rise, although trading volume has dropped 28.79% to $587.7 million. ADA still faces resistance zones that shape the December Cardano Price Prediction outlook.
A recent market update https://coinmarketcap.com/community/post/371545140 highlighted ADA’s behavior on the lower timeframes, noting its price movement near a critical support zone and how this structure could determine the next move.
According to the analyst breakdown shared on Finora Telegram, ADA is hovering around $0.3876 with key resistance at $0.3937.
If that level rejects, the token may revisit lower zones, but a clean breakout could push it toward $0.4114 or $0.4274.
These levels matter because the broader crypto market is showing fragmented strength across altcoins. Traders are also looking at new altcoin to watch narratives that could outperform top crypto under $1 assets.
With on-chain activity and liquidity shifting frequently, ADA needs stronger market sentiment and clearer buying pressure to rebuild momentum through December. This makes the Cardano Price Prediction outlook more tactical than directional, especially as volatility remains high.
December Catalysts and Technical Factors
The December setup focuses largely on short-term reactions to support and how quickly buyers regain control. Cardano’s technical structure shows mixed signals, and its performance will depend on how the crypto market processes the recent shifts in liquidity and demand.
Crypto trends this month indicate selective accumulation rather than broad buying patterns, and that keeps ADA in a cautious zone heading into 2026.
Major Remittix Update Gains Attention
As traders review December setups https://x.com/remittix/status/1989646857090523423, Remittix https://remittix.io has gained significant visibility after a long list of updates that strengthen its position among digital assets. The Remittix token is priced at $0.119, with more than $28.4 million raised from private funding and over 692.6 million tokens sold.
The project achieved a milestone by launching the Remittix Wallet on the Apple App Store https://x.com/remittix/status/1989646857090523423, allowing users to store and manage assets while preparing for upcoming crypto-to-fiat features. Android rollout is already underway, and the December update will introduce more functions that expand its PayFi system.
Remittix is also verified by CertiK https://skynet.certik.com/projects/remittix-labs, with the team fully KYC-approved and the project ranked number one in pre-launch tokens. You can verify this through the CertiK Audit and Team KYC pages. The community has also seen the beta wallet in action through the shared wallet demo, showcasing real progress rarely seen in early-stage crypto projects.
Key Remittix Highlights
● Wallet live on App Store with Android next
● Full CertiK verification building global trust
● Private funding raised above $28.4 million
● Beta Program open to Top 10 purchasers weekly
● $250,000 Giveaway boosting community activity
Future listings on BitMart and LBank have already been confirmed as part of upcoming CEX integrations. The project is also nearing the $30 million mark, which will unlock a major listing reveal.
A December Shift Worth Watching
The final Cardano price prediction question for December is whether ADA can reclaim higher levels or if stronger competitors gain more traction. With Remittix advancing rapidly and building real-world utility, ADA faces pressure to deliver more visible progress within the crypto market.
This month could shape how investors compare established altcoins with newer, fast-moving projects viewed as some of the best crypto to buy now.
Discover the future of PayFi with Remittix by checking out their project here:
Website: https://remittix.io/
Socials: https://linktr.ee/remittix
$250,000 Giveaway: https://gleam.io/competitions/nz84L-250000-remittix-giveaway
Frequently Asked Questions
1. Is Cardano still a strong asset for long-term holders?
ADA remains a relevant cryptocurrency due to its smart contract features, strong community, and steady development, but short-term movements depend heavily on market sentiment.
2. What affects Cardano Price Prediction for December?
Technical reactions near support, trading volume, and broader crypto market conditions shape ADA’s December outlook.
3. Which crypto projects are considered strong competitors right now?
Projects with active development, audits, and real utility like Remittix often gain more attention from crypto investors.
4. How do I identify promising new altcoin to watch opportunities?
Look for projects releasing products early, providing clear utility, and maintaining transparency through audits or public testing.
5. What role does liquidity play in crypto market performance?
High liquidity on CEX and DEX platforms helps stabilize price movements and attracts larger trading interest across digital assets.
Disclaimer: This article is for informational purposes only and does not constitute financial advice. Cryptocurrency investments carry risk, including total loss of capital. Readers should conduct independent research and consult licensed advisors before making any financial decisions.
Crypto Press Release Distribution by https://btcpresswire.com
This release was published on openPR.
Celia Quansah is an English rugby sevens player who plays for Leicester Tigers Women. She was selected as a member of the Great Britain women’s national rugby sevens team for the 2020 Summer Olympics. Born at Twickenham, England. Born to a Ghanaian father and English mother, Quansah grew up in Twickenham. She participated in athletics, winning the long jump event at the 2011 School Games, and represented England internationally in heptathlon, competing at the British Championships against Jessica Ennis-Hill. Whilst at university, she took up rugby. After playing for six months, she was invited to join the England Sevens programme for 2018/19, and played for the winning Great Britain team at the 2019 Rugby Europe Women’s Sevens Olympic Qualifying Tournament.
She was selected as a member of the Great Britain women’s national rugby sevens team for the 2020 Summer Olympics. She was named in the England squad for the 2022 Rugby World Cup Sevens – Women’s tournament held in Cape Town, South Africa in September 2022.
Women Fitness President Ms. Namita Nayyar catches up with Celia Quansah – an exceptionally talented and accomplished English rugby sevens Olympic athlete. Here she talks about her fitness journey and the success story.
You were born in Twickenham, England. You participated in athletics, winning the long jump event at the 2011 School Games, and represented England internationally in heptathlon. While at university, took up rugby and after playing for six months, were invited to join the England Sevens programme for 2018-19, and played for the winning Great Britain team at the 2019 Rugby Europe Women’s Sevens Olympic Qualifying Tournament. This later propelled your career to the height where you have been at the top of English women’s rugby. Tell us more about your professional journey of exceptional hard work, tenacity, and endurance?
I’ve always loved sport, growing up I would try anything I had the opportunity to. At primary school I was introduced to sports like tag rugby, cricket and athletics. I think being exposed to sport at a young age developed the competitive nature in me and I got so much enjoyment from it, which never went away really.
I started playing rugby because I was desperate for a new challenge, and felt like I wasn’t going to unlock my full potential in Athletics, but I said to myself I was only going to do it if I was going to play for England, I wanted to be the best, so that was in my head from the moment I picked up a rugby ball. It was a steep learning curve being thrown into an international setup with very little rugby knowledge, so that took a lot of confidence and hard work.
I picked up a lot of niggles (injuries) early on, as my body wasn’t used to the demands of the new sport, but after a year or so I was able to play freely and had a good stint being injury free. That was when I really saw my progression accelerate and I found myself playing on the world stage in front of thousands of fans in some of the biggest stadiums around the world, which are moments I will never forget.
In 2021, at the top of my game post Tokyo Olympics, I ruptured my first ACL. This was my first ‘big’ injury and it was devastating. When it happened, I remember laying on the pitch while the physio assessed me, and counting ahead 9 months (the average time it takes to return from an ACL injury) which took me to a week before our first match at the Commonwealth Games.
In that moment I knew I was going to do everything I could to get myself back for that tournament. After talks with my medical team to discuss the risks, we decided we would throw the kitchen sink at it, and against the odds, I returned to playing after 7 months and was selected for the 2022 Commonwealth Games. A dream comes true.
Unfortunately after a short 6 months back on the pitch, at the Cape Town HSBC World Series tournament, I was high tackled, and dislocated my other knee causing significant injuries including an ACL and MCL rupture and Meniscus tear. At first, my mindset was similar to my first ACL, ‘we go again’ I thought. But over time, this injury took its toll, I felt so hard done by and questioned a lot, why me? I struggled in a camp based program, to get the support I needed and wanted which affected me massively over time. I was however, extremely fortunate to have the support from external sources such as The RPA and The IRU.
After multiple scans, two surgeries, injections and countless physio and psychology sessions, I returned to playing on the HSBC World Series in February 2024 where I was able to start my journey back to loving rugby again. Still, 10 months later, I’m on that journey back to full confidence, full fitness and full enjoyment for the game, but I’m determined to get there.

It is a dream for a rugby player to play in the Olympics. You were selected as a member of the Great Britain women’s national rugby sevens team for the 2020 Summer Olympics. Tell us more about this spectacular achievement of yours?
Being an Olympian has always been my ultimate dream, it sounds silly but growing up I knew I was going to make it happen. I did think it was going to be in athletics, but life took me on a different path. A lot of rugby players actually dream of playing in a World Cup, rather than an Olympics as that has traditionally been the ‘pinnacle’. However for me, the Olympics were always my dream and it still feels strange to be able to say I’ve achieved it.
Like anything, it becomes normal over time, but it’s really lovely when people remind you of how special it really is. When you’re in the elite sport bubble, things that aren’t that normal become normal, like being an Olympian? Haha. I am so, so grateful for the coaches who took a chance on me as a 21 year old heptathlete, and in 4 years, nurtured me into a player worthy of an Olympic shirt. It really was one of the best experiences of my life.
Full Interview is Continued on Next Page
This interview is exclusive and taken by Namita Nayyar, President of womenfitness.net, and should not be reproduced, copied, or hosted in part or in full anywhere without express permission.
All Written Content Copyright © 2025 Women Fitness
Disclaimer
The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.